Association Between the Time from Onset to Nadir and the Clinical Characteristics in Patients with Guillain–Barré Syndrome
Abstract
Objective This study aimed to elucidate the clinical parameters of Guillain-Barré syndrome (GBS), including the short-term outcomes, associated with the time from onset to nadir (TON). Methods This single-center retrospective observational study divided patients with GBS into rapidly and nonrapidly progressive groups based on the TON (nadir reached within 7 days or after 7 days, respectively). The clinical features and outcomes were compared between the groups. Patients or Materials A total of 26 patients with GBS who underwent antiganglioside antibody testing between April 2015 and May 2025 were enrolled. The short-term outcomes were evaluated using the Hughes Functional Grading Scale (HFGS) scores at nadir and at discharge. Results The rapidly and nonrapidly progressive groups included 17 and 9 patients, respectively. Posttreatment deterioration and the need for mechanical ventilation were observed only in the rapidly progressive group, with significantly higher frequencies than in the nonrapidly progressive group (p = 0.009 and p = 0.023, respectively). Furthermore, mean HFGS scores at nadir were significantly higher in the rapidly progressive group (3.8 vs. 2.6; p = 0.018), whereas no significant differences were observed at admission or discharge (p = 0.21 and p = 0.14, respectively). Conclusion Regarding short-term outcomes, patients with shorter TON experienced greater disease severity at nadir but ultimately showed discharge outcomes comparable to those of patients with longer TON. In GBS, TON may serve as a predictor of short-term disease severity, but it does not necessarily correlate with the outcomes at discharge.
Related
- Characteristics of Patients with Guillain-Barré Syndrome and Fisher Syndrome in Complement Activation: A Retrospective Study
- Efgartigimod in the treatment of severe Guillain–Barre syndrome with overlapping autoantibody syndrome: a case report and updated clinical review
- Clinical characteristics and preliminary discriminatory value of low triiodothyronine syndrome in patients with peritoneal dialysis-associated peritonitis : A cross-sectional study
- The pathogenic and clinical characteristics of community-acquired and hospital-acquired co-infection in patients hospitalized with severe fever with thrombocytopenia syndrome
- Treatment Adherence and its Association with Demographic Characteristics and Clinical Factors Among Patients with Hypertension: A Cross-Sectional, Descriptive-Correlational Study.
BibTeX
@article{muramatsu2026association,
title = {{Association Between the Time from Onset to Nadir and the Clinical Characteristics in Patients with Guillain–Barré Syndrome}},
author = {Ryoko Muramatsu and Taiki Matsubayashi and Jun Terai and Misako Furuki and Ayumi Uchibori and Masato Obayashi},
journal = {Internal Medicine},
year = {2026},
month = aug,
doi = {10.2169/internalmedicine.7317-26},
url = {https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_7317-26/_article},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Association Between the Time from Onset to Nadir and the Clinical Characteristics in Patients with Guillain–Barré Syndrome
AU - Ryoko Muramatsu
AU - Taiki Matsubayashi
AU - Jun Terai
AU - Misako Furuki
AU - Ayumi Uchibori
AU - Masato Obayashi
PY - 2026
DA - 2026/08/08
JO - Internal Medicine
DO - 10.2169/internalmedicine.7317-26
UR - https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_7317-26/_article
AB - Objective This study aimed to elucidate the clinical parameters of Guillain-Barré syndrome (GBS), including the short-term outcomes, associated with the time from onset to nadir (TON). Methods This single-center retrospective observational study divided patients with GBS into rapidly and nonrapidly progressive groups based on the TON (nadir reached within 7 days or after 7 days, respectively). The clinical features and outcomes were compared between the groups. Patients or Materials A total of 26 patients with GBS who underwent antiganglioside antibody testing between April 2015 and May 2025 were enrolled. The short-term outcomes were evaluated using the Hughes Functional Grading Scale (HFGS) scores at nadir and at discharge. Results The rapidly and nonrapidly progressive groups included 17 and 9 patients, respectively. Posttreatment deterioration and the need for mechanical ventilation were observed only in the rapidly progressive group, with significantly higher frequencies than in the nonrapidly progressive group (p = 0.009 and p = 0.023, respectively). Furthermore, mean HFGS scores at nadir were significantly higher in the rapidly progressive group (3.8 vs. 2.6; p = 0.018), whereas no significant differences were observed at admission or discharge (p = 0.21 and p = 0.14, respectively). Conclusion Regarding short-term outcomes, patients with shorter TON experienced greater disease severity at nadir but ultimately showed discharge outcomes comparable to those of patients with longer TON. In GBS, TON may serve as a predictor of short-term disease severity, but it does not necessarily correlate with the outcomes at discharge.
SN - 1349-7235
SN - 0918-2918
ER -